when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

PHYTONADIONE · catalysts · pharmadog

← back to PHYTONADIONE

Catalysts for PHYTONADIONE

37 tracked

phase 2 completion

Tufts Medical Center — phytonadione (Phase II Trial Completion)

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

PHYTONADIONE — FDA approval

PHYTONADIONE — FDA approval

PHYTONADIONE — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

VITAMIN K1 (PHYTONADIONE) — FDA approval

← prevpage 1 of 2next →

$SIGY0.04000.00%

$AMRX17.90-1.16%